🇺🇸 FDA
Pipeline program

Pozelimab

R3918-HV-1982

Phase 1 small_molecule completed

Quick answer

Pozelimab for Healthy is a Phase 1 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Alnylam Netherlands B.V.
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials